AURKA overexpression
|
Estrogen Receptor Positive Breast Cancer
|
AURKA overexpression
|
Estrogen Receptor Positive Breast Cancer
|
tamoxifen Resistant: C3 – Early Trials
|
tamoxifen Resistant: C3 – Early Trials
|
AURKA overexpression
|
Adrenal Cortex Carcinoma
|
AURKA overexpression
|
Adrenal Cortex Carcinoma
|
SA033 + AMG 900 Sensitive: D – Preclinical
|
SA033 + AMG 900 Sensitive: D – Preclinical
|
AURKA overexpression
|
Adrenal Cortex Carcinoma
|
AURKA overexpression
|
Adrenal Cortex Carcinoma
|
mitotane + AMG 900 Sensitive: D – Preclinical
|
mitotane + AMG 900 Sensitive: D – Preclinical
|
AURKA overexpression
|
Adrenal Cortex Carcinoma
|
AURKA overexpression
|
Adrenal Cortex Carcinoma
|
AMG 900 Sensitive: D – Preclinical
|
AMG 900 Sensitive: D – Preclinical
|
AURKA overexpression
|
Esophageal Cancer
|
AURKA overexpression
|
Esophageal Cancer
|
MLN8237 Sensitive: D – Preclinical
|
MLN8237 Sensitive: D – Preclinical
|